Comparative Analysis of the Clinical Presentation of Individuals Who Test Positive or Negative for SARS-CoV-2: Results from a Test Street Study
- PMID: 39066194
- PMCID: PMC11281701
- DOI: 10.3390/v16071031
Comparative Analysis of the Clinical Presentation of Individuals Who Test Positive or Negative for SARS-CoV-2: Results from a Test Street Study
Abstract
The common cold, the flu, and the 2019 coronavirus disease (COVID-19) have many symptoms in common. As such, without testing for severe-acute-respiratory-syndrome-related coronavirus 2 (SARS-CoV-2), it is difficult to conclude whether or not one is infected with SARS-CoV-2. The aim of the current study was to compare the presence and severity of COVID-19-related symptoms among those who tested positive or negative for the beta variant of SARS-CoV-2 (B.1.351) and identify the clinical presentation with the greatest likelihood of testing positive for SARS-CoV-2. n = 925 individuals that were tested for SARS-CoV-2 at Dutch mass testing sites (i.e., test streets) were invited to complete a short online survey. The presence and severity of 17 COVID-19-related symptoms were assessed. In addition, mood, health correlates, and quality of life were assessed for the week before the test. Of the sample, n = 88 tested positive and n = 837 tested negative for SARS-CoV-2. Individuals who tested positive for SARS-CoV-2 reported experiencing a significantly greater number, as well as greater overall symptom severity, compared to individuals who tested negative for SARS-CoV-2. A binary logistic regression analysis revealed that increased severity levels of congestion, coughing, shivering, or loss of smell were associated with an increase in the odds of testing positive for SARS-CoV-2, whereas an increase in the severity levels of runny nose, sore throat, or fatigue were associated with an increase in the odds of testing negative for SARS-CoV-2. No significant differences in mood or health correlates were found between those who tested positive or negative for SARS-CoV-2, except for a significantly higher stress score among those who tested negative for SARS-CoV-2. In conclusion, individuals that tested positive for SARS-CoV-2 experienced a significantly greater number and more severe COVID-19-related symptoms compared to those who tested negative for SARS-CoV-2. Experiencing shivering and loss of smell may be the best indicators for increased likelihood of testing positive for SARS-CoV-2.
Keywords: COVID-19; SARS-CoV-2; loss of smell; mood; predictors; quality of life; sleep quality; symptoms.
Conflict of interest statement
Over the past 3 years, J.V. has acted as a consultant/advisor for Eisai, KNMP, Med Solutions, Red Bull, Sen-Jam Pharmaceutical, and Toast! J.G. is part-time employee of Danone and received research grants from Nutricia research foundation, Top Institute Pharma, Top Institute Food and Nutrition, GSK, STW, NWO, Friesland Campina, CCC, Raak-Pro, and EU. P.K. is CEO of PanGenix. The other authors have no potential conflicts of interest to disclose.
Figures


Similar articles
-
COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2.PLoS One. 2021 Dec 10;16(12):e0260879. doi: 10.1371/journal.pone.0260879. eCollection 2021. PLoS One. 2021. PMID: 34890441 Free PMC article.
-
Presence of gustatory and olfactory dysfunction in the time of the COVID-19 pandemic.BMC Infect Dis. 2021 Jun 26;21(1):612. doi: 10.1186/s12879-021-06294-2. BMC Infect Dis. 2021. PMID: 34174816 Free PMC article.
-
Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people.PLoS Med. 2021 Sep 28;18(9):e1003777. doi: 10.1371/journal.pmed.1003777. eCollection 2021 Sep. PLoS Med. 2021. PMID: 34582457 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2021 Feb 23;2(2):CD013665. doi: 10.1002/14651858.CD013665.pub2. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 20;5:CD013665. doi: 10.1002/14651858.CD013665.pub3. PMID: 33620086 Free PMC article. Updated.
-
Universal screening for SARS-CoV-2 infection: a rapid review.Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718. Cochrane Database Syst Rev. 2020. PMID: 33502003 Free PMC article.
References
-
- Ministerie van Volksgezondheid, Welzijn, en Sport Besluiten naar Aanleiding van OMT Advies 25 mei 2020. [(accessed on 20 January 2024)]. Available online: https://open.overheid.nl/documenten/ronl-739c3a75-a1bc-4083-9bf5-1d985e4....
-
- Centers for Disease Control and Prevention Symptoms of COVID-19. [(accessed on 1 November 2020)]; Available online: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.
-
- Centers for Disease Control and Prevention About Rhinoviruses. [(accessed on 24 June 2024)]; Available online: https://www.cdc.gov/rhinoviruses/about/index.html.
-
- Centers for Disease Control and Prevention Flu Symptoms & Complications. [(accessed on 17 January 2024)]; Available online: https://www.cdc.gov/flu/symptoms/symptoms.htm.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous